To view more alumni events, click here.
The Association for Computing Machinery’s Annual Lecture in Memory of Nathan Krasnopoler will be held at 4 p.m. on Friday, May 2 in Hackerman Hall B-17 on the Johns Hopkins University’s Homewood campus.
Speaker Greg Kroah-Hartman of the Linux Foundation will speak on “The Linux Kernal: too fast and too big to be correct.” In his talk, Kroah-Hartman will discuss details of Linux kernel development, the current rate of change, who is doing the work and how all this goes against “everything you have learned in school about doing software development.” Kroah-Hartman also will introduce the audience members to ways they can get involved in Linux kernel development.
This lecture is sponsored by the Nathan Krasnopoler Memorial Fund, established at the Whiting School of Engineering to benefit the Johns Hopkins’ chapter of the Association for Computing Machinery. For more information: Association for Computing Machinery’s Annual Lecture in Memory of Nathan Krasnopoler
Kimberly Jones, professor and chair of the Department of Civil Engineering at Howard University, will deliver The Charles and Mary O’Melia Lecture in Environmental Science at 3 p.m. on Tuesday, Sept. 29 in Gilman 50.
Jones’ research interests include developing membrane processes for environmental applications, physical-chemical processes for water and wastewater treatment, remediation of emerging contaminants, drinking water quality, and environmental technology.
The Association for Computing Machinery’s Annual Lecture in Memory of Nathan Krasnopoler will be held at 4 p.m. on Monday, Dec. 7 in Hackerman Hall B-17 on the Johns Hopkins University’s Homewood campus.
Mike Ambinder, a senior experimental psychologist at Valve, will deliver a lecture titled “Shipping Something: How Valve Makes Products and How You Can, Too.” The talk will walk listeners through the process that Valve (developer of Half-Life, Team Fortress, DOTA and more) uses to create, iterate, and ship its products, and how that process can yield the skills and experience necessary to succeed in the software industry. The key “takeaway” from this lecture is that what works for Valve can also work for undergraduates looking for their first jobs, and can help them develop the ability to get where they want to go.
This lecture is sponsored by the Nathan Krasnopoler Memorial Fund, established at the Whiting School of Engineering to benefit the Johns Hopkins’ chapter of the Association for Computing Machinery.
R. Rhodes Trussell, Chairman and Founder of LA-based Trussell Technologies, Inc., will deliver the 2016 Earnest and Agnes Gloyna Distinguished Lecture in Environmental Engineering from 3 to 4:15 p.m. on Tuesday, Oct. 18. The location of this lecture will be announced closer to the date of the event. A reception will follow. This event is hosted by the Department of Geography and Environmental Engineering.
Robert M. Nerem (Georgia Institute of Technology) presents “Regenerative Medicine: The Hype, the Hope, and the Future” as part of a special seminar hosted by the Department of Biomedical Engineering, the Institute for NanoBioTechnology, and the Translational Tissue Engineering Center.
Abstract: Although the underlying concepts of tissue engineering and regenerative medicine go back more than 75 years, the term tissue engineering actually was only “coined” in the 1980s. This was followed by the 1990s being the “go-go” years with stem cells emerging as a technology, an industry developing, and the term regenerative medicine beginning to be used. There also was a lot of hype, and following the turn of the century the field entered what might be called the “sobering” years, with private sector activity falling significantly even though the science continued to advance. The last decade, however, has all the marks of being “back to the future.” Advances in cell-based therapies have been fueled by advances in stem cell science and technology and the discovery of what is required to reprogram somatic cells into stem cells, known as induced pluripotent stem (iPS) cells. For cellular therapies, a key question is what is the mechanism of action? For a specific therapy, is the mechanism one of cell replacement or is it a paracrine effect? If the latter, is it possible that one could introduce the appropriate biological signals without the use of cells? In this case the discussion shifts from “my cell is better than your cell” to “my biological signals are better than yours.” Whatever the case, one of the “holy grails” is the neurodegenerative diseases/disorders and the repair/regeneration of the central nervous system. Instead of the mixture of hype and hope in the past, and with an aging population providing the threat of a “tsunami” of neural disorders, regenerative medicine offers the real possibility of cures to these diseases/disorders in the future.